Takeda Pharmaceutical
TAK
#495
Rank
NZ$81.83 B
Marketcap
NZ$24.59
Share price
0.10%
Change (1 day)
6.91%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$85.90 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are NZ$85.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31NZ$86.01 B-0.49%
2024-03-31NZ$86.44 B-5.05%
2023-03-31NZ$91.04 B2.56%
2022-03-31NZ$88.77 B-11.24%
2021-03-31NZ$100.01 B-20.94%
2020-03-31NZ$126.49 B11.32%
2019-03-31NZ$113.62 B318.42%
2018-03-31NZ$27.15 B-11.62%
2017-03-31NZ$30.72 B31.95%
2016-03-31NZ$23.28 B-0.43%
2015-03-31NZ$23.38 B3.26%
2014-03-31NZ$22.65 B4.35%
2013-03-31NZ$21.70 B2.65%
2012-03-31NZ$21.14 B106.36%
2011-03-31NZ$10.24 B3.35%
2010-03-31NZ$9.91 B-21.49%
2009-03-31NZ$12.62 B97.13%
2008-03-31NZ$6.40 B-11.72%
2007-03-31NZ$7.25 B-25.45%
2006-03-31NZ$9.73 B37.01%
2005-03-31NZ$7.10 B-11.32%
2004-03-31NZ$8.00 B6.26%
2003-03-31NZ$7.53 B-18.76%
2002-03-31NZ$9.27 B-6.24%
2001-03-31NZ$9.89 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$196.70 B 128.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$114.39 B 33.16%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$200.33 B 133.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$108.34 B 26.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
NZ$1.87 B-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$3.50 B-95.92%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
NZ$139.50 B 62.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$106.17 B 23.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$134.50 B 56.57%๐Ÿ‡บ๐Ÿ‡ธ USA